Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Argan (AGX)

Argan posts record Q4 diluted EPS of $2.22 as revenue rises 41% to $232.5 million

Positive Impact 3 of 5 earnings Written later

Argan reported fourth quarter and fiscal 2025 results for the period ended January 31, 2025. Quarterly revenue rose 41% to $232.5 million, and net income was $31.4 million, or $2.22 per diluted share, compared with $0.89 a year earlier. For the full year, revenue rose 52.5% to $874.2 million and net income was $85.5 million, or $6.15 per diluted share.

Key points

  • Q4 gross margin was 20.5%, up from 14.4% a year earlier; EBITDA was $39.3 million versus $17.6 million
  • Fiscal 2025 net income was $85.5 million, or $6.15 per diluted share, versus $32.4 million, or $2.39, in fiscal 2024
  • Project backlog was $1.4 billion at January 31, 2025, up from $757 million a year earlier; the company reported no debt
  • Quarterly cash dividend was $0.375 per share, up from $0.300 a year earlier

The filing

CompanyArgan (AGX)
Form8-K, current report
Filed with the SECMar 27, 2025, 4:10 PM ET
Accession number0001558370-25-003812

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 27, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.